Background
Methods
Study participants
Biospecimen and clinical data collection
MetS in children: MetS case selection
IDEFICS MetS risk score derivation
Serum metabolome analysis
Covariates
Dietary assessment
Physical activity
Other covariates
Statistical analysis
Results
Participants characteristics
Characteristic | MetS caseb (n = 228) | MetS control (n = 228) | Overall (n = 456) |
---|---|---|---|
Age (years) | 5.14 (0.28) | 5.16 (0.29) | 5.15 (0.29) |
Sex (female) | 115 (50.4%) | 115 (50.4%) | 230 (50.4%) |
Daily night sleep (hours) | 10.88 (0.65) | 10.93 (0.61) | 10.90 (0.63) |
Physical activity (weighted daily minutes) | 237 (71) | 227 (71) | 232 (71) |
Diet quality Index | − 0.82 (3.4) | − 1.37 (3.45) | − 1.1 (3.43) |
Social disadvantage index | |||
Low (0–1) | 164 (73.5%) | 163 (75.1%) | 327 (74.0%) |
Moderate (2–3) | 43 (19.3%) | 48 (22.1%) | 91 (21.0%) |
High (4–5) | 16 (7.2%) | 6 (2.8%) | 22 (5.0%) |
Screen time exposure | |||
Low exposure (< 2 h) | 53 (23.3%)* | 71 (31.8%) | 124 (28.0%) |
High exposure (≥ 2 h) | 174 (76.7%)* | 152 (68.2%) | 326 (72.0%) |
Systolic blood pressure (mm Hg) | 101.30 (8.31)*** | 97.37 (8.03) | 99.33 (8.40) |
Diastolic blood pressure (mm Hg) | 61.18 (5.44)*** | 59.25 (5.42) | 60.21 (5.51) |
Total cholesterol (mmol/L) | 4.13 (0.65) | 4.07 (0.72) | 4.10 (0.69) |
HDL cholesterol (mmol/L) | 1.43 (0.32)* | 1.37 (0.31) | 1.40 (0.31) |
LDL cholesterol (mmol/L) | 2.38 (0.61) | 2.37 (0.63) | 2.37 (0.62) |
Triglycerides (mmol/L) | 0.71 (0.31) | 0.69 (0.29) | 0.70 (0.30) |
Fasting blood glucose (mmol/L) | 4.75 (0.38)*** | 4.52 (0.31) | 4.63 (0.37) |
BMI (kg/m2) | 16.66 (1.80)*** | 15.13 (0.90) | 15.89 (1.62) |
BMI-for-age z-score (WHO) | 0.84 (1.01)*** | − 0.12 (0.64) | 0.36 (0.97) |
Waist circumference (cm) | 53.43 (4.47)*** | 49.97 (2.59) | 51.70 (4.04) |
Waist circumference-to-height | 0.48 (0.04)*** | 0.45 (0.02) | 0.47 (0.03) |
Sum of skinfolds (mm) | 20.50 (6.78)*** | 16.80 (4.14) | 18.63 (5.91) |
z-BMI ≥ 75th percentile AND waist circumference ≥ 90th percentile | 45 (19.7%) | 0 (0%) | 45 (9.9%) |
z-BMI ≥75th percentile AND median ≤ waist circumference < 90th percentile | 89 (39.0%) | 0 (0%) | 89 (19.5%) |
z-BMI ≥75th percentile AND systolic blood pressure ≥ 90th percentile | 22 (9.7%) | 0 (0%) | 22 (4.8%) |
Fasting glucose ≥ 90th percentile | 70 (30.7%) | 0 (0%) | 70 (15.4%) |
Maternal GDM | 75 (32.9%) | 0 (0%) | 75 (16.4%) |
Prevalence of MetS and the IDEFICS MetS risk score
Characteristic | MetS cases (n = 228) | MetS control (n = 228) | Overall (n = 456) |
---|---|---|---|
IDEFICS MetS score | 1.00 (2.06) | − 0.90 (1.58) | 0.05 (2.07) |
z-waist circumference | 0.50 (1.29) | − 0.6 (0.94) | − 0.05 (1.25) |
z-systolic blood pressure | 0.38 (0.95) | − 0.08 (0.97) | 0.15 (0.99) |
z-diastolic blood pressure | − 0.19 (0.87) | − 0.50 (0.89) | − 0.34 (0.89) |
z-triglycerides | 0.51 (0.73) | 0.47 (0.72) | 0.49 (0.72) |
z-HDL-cholesterol | 0.41 (0.88) | 0.22 (0.89) | 0.32 (0.89) |
z-lipids (triglycerides-HDL) | 0.05 (0.66) | 0.12 (0.66) | 0.08 (0.66) |
z-glucose | 0.36 (0.83) | − 0.13 (0.67) | 0.11 (0.79) |
Metabolite profiling in 5-year-old children
Comparison of serum metabolite profiles in MetS cases and MetS controls
Metabolite | OR | 95% CI | p- |
---|---|---|---|
Glucose | 1.55 | (1.25–1.96) | 0.0001 |
Alanine | 1.42 | (1.16–1.75) | 6.8e−4 |
Tyrosine | 1.34 | (1.10–1.64) | 0.004 |
Monomethylarginine | 1.35 | (1.09–1.66) | 0.005 |
Tryptophan | 0.79 | (0.65–0.96) | 0.017 |
Choline | 0.79 | (0.64–0.96) | 0.023 |
Deoxy carnitine | 1.25 | (1.03–1.52) | 0.028 |
Carnitine | 1.24 | (1.03–1.52) | 0.029 |
Threonine | 1.24 | (1.02–1.52) | 0.031 |
Lysine | 1.23 | (1.01–1.50) | 0.043 |
Arginine | 1.22 | (1.00–1.49) | 0.048 |
Unknown 248.0711 | 0.82 | (0.67–1.00) | 0.049 |
Glutamine/glutamate | 0.83 | (0.68–1.00) | 0.053 |
Association of serum metabolite profiles with the continuous MetS score
Adjustment for screen time exposure, diet quality score, physical activity, sleep time, and maternal social disadvantage index | Adjustment for screen time exposure, diet quality score, physical activity, sleep time, maternal social disadvantage index, sex and age | |||||||
---|---|---|---|---|---|---|---|---|
Metabolite | Estimate | SE | z value | p- | Estimate | SE | z value | p- |
Glucosea | 0.64 | 0.095 | 6.70 | 3.9e−11b | 0.65 | 0.095 | 6.80 | 3.50e−11b |
Alaninea | 0.56 | 0.097 | 5.76 | 1.3e−10b | 0.55 | 0.098 | 5.62 | 3.41e−08b |
Tyrosinea | 0.42 | 0.098 | 4.25 | 2.1e−5b | 0.41 | 0.099 | 4.16 | 3.87e−05b |
Threoninea | 0.35 | 0.099 | 3.57 | 4.2e−4b | 0.34 | 0.10 | 3.42 | 0.001 |
Carnitinea | 0.41 | 0.097 | 4.17 | 3.4e−5b | 0.41 | 0.098 | 4.19 | 3.35e−05b |
Tryptophana | − 0.36 | 0.099 | − 3.59 | 4.6e−4b | − 0.36 | 0.099 | − 3.62 | 3.2e−4b |
Acetylcarnitine | − 0.42 | 0.098 | − 4.26 | 3.1e−5b | − 0.42 | 0.098 | − 4.23 | 2.92e−05b |
Hydroxybutyric acids | − 0.38 | 0.098 | − 3.89 | 2.1e−4b | − 0.39 | 0.098 | − 3.96 | 8.64e−05b |
Methionine | 0.34 | 0.099 | 3.44 | 0.001 | 0.32 | 0.10 | 3.24 | 0.001 |
Proline | 0.32 | 0.10 | 3.15 | 0.002 | 0.31 | 0.10 | 3.06 | 0.002 |
Arginine | 0.30 | 0.10 | 2.95 | 0.003 | 0.29 | 0.10 | 2.86 | 0.004 |
Monomethylargininea | 0.29 | 0.10 | 2.79 | 0.006 | 0.30 | 0.10 | 2.85 | 0.005 |
Glutamic acid | 0.27 | 0.10 | 2.72 | 0.007 | 0.26 | 0.10 | 2.57 | 0.011 |
Unknown 129.066 | − 0.27 | 0.10 | − 2.62 | 0.009 | − 0.26 | 0.10 | − 2.57 | 0.011 |
Glutamine/glutamatea | − 0.25 | 0.10 | − 2.53 | 0.012 | − 0.25 | 0.10 | − 2.44 | 0.015 |
Lysinea | 0.23 | 0.10 | 2.26 | 0.024 | 0.22 | 0.10 | 2.12 | 0.035 |
3-methyl-2-oxovaleric acid | − 0.22 | 0.099 | − 2.26 | 0.024 | − 0.22 | 0.099 | − 2.24 | 0.026 |